AGF Investments Inc’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,800
Closed -$161K 756
2021
Q3
$161K Sell
4,800
-438
-8% -$16.5K ﹤0.01% 651
2021
Q2
$209K Buy
+5,238
New +$205K ﹤0.01% 549
2020
Q4
Sell
-49
Closed -$2K 779
2020
Q3
$2K Hold
49
﹤0.01% 782
2020
Q2
$3K Sell
49
-5,453
-99% -$303K ﹤0.01% 736
2020
Q1
$260K Buy
+5,502
New +$307K ﹤0.01% 496

Other funds holding IONS

AGF Investments Inc's IONS Position: Q4 2021 in Review

AGF Investments Inc sold out of Ionis Pharmaceuticals (IONS) in Q4 2021, closing a stake of 4,800 shares — an estimated $161K sold.

AGF Investments Inc first reported a position in IONS in Q1 2020 and held it in 5 quarters. The position peaked at $260K in Q1 2020. 340 funds tracked by Wall St. Rank hold IONS as of Q4 2021.

  • AGF Investments Inc reported no remaining Ionis Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • AGF Investments Inc sold 4,800 Ionis Pharmaceuticals shares in Q4 2021, an estimated $161K.
  • AGF Investments Inc first reported a position in Ionis Pharmaceuticals in Q1 2020 and held it in 5 quarters.
  • AGF Investments Inc's Ionis Pharmaceuticals position peaked at $260K in Q1 2020.
  • 340 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2021.

Based on AGF Investments Inc's 13F filing for Q4 2021, filed 1 Feb 2022.